Professional Documents
Culture Documents
Nashville, TN, April 02, 2019 --(PR.com)-- Vesalio announces it has executed multiple exclusive
distribution agreements in Europe, Latin America, Asia and the Middle East and now has market
coverage in 39 countries for the NeVa™ Neuro-thrombectomy System.
Along with the increased market and registration activities, Vesalio is expanding its training programs to
include Vesalio Clot Interaction Labs™ and AIS Simulation Workshops with Vesalio's proprietary flow
model for new channel partners and physicians. “We are receiving strong industry interest in our unique
product line. Top global distribution companies are approaching Vesalio to augment their market
presence with NeVa in the high growth thrombectomy space,” remarked William von Brendel, VP,
International Business.
To fuel its growth, Vesalio has committed to expand its international exhibit sponsorship in key
neurovascular congresses and live teaching courses in 2019. “We will increase our presence in 2019 by
adding WLNC (May 1-3, Barcelona) and LINNC (June 3-5, Paris) to the ESMINT (Sept. 4-6, Nice) and
SLICE (Sept. 30 - Oct. 2, Nice) congresses where we exhibited in 2018. This is in response to key
opinion leaders and congress organizers expressing interest in the outstanding clinical results obtained by
clinicians with NeVa,” commented Diane Demet Tangun, VP, Market Development.
For further information, visit www.vesalio.com or email info@vesalio.com. NeVa trademarks and patents
are the property of Vesalio.
Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Vesalio
William von Brendel
858-335-5790
Contact via Email
www.vesalio.com
News Image:
Page 2/2
PR.com Press Release Distribution Terms of Use